Abstract:Objective: Heat shock proteins (HSPs) are cytoprotective proteins. Vascular endothelial growth factor (VEGF) is the most potent angiogenic factor. This study aimed to elucidate the possible role of cytoprotection and angiogenesis on cardiac function after bone marrow cell transplantation (BMT). Methods: Myocardial infarction was induced in inbred Lewis rats by left anterior descending artery ligation. A total of 5 x 10(6) bone marrow-mononuclear cells were transplanted into the ischemic zone by direct injection. At 1, 3, 7, 14 and 28 days post-transplantation, cardiac function was evaluated by echocardiography. The expressions of HSP32, HSP70 and VEGF were assessed by immunofluorescence and RT-PCR. The number of vessels was examined by immunohistochemistry. The differentiation of the transplanted cells was determined by immunofluorescence. Results: Echocardiography showed BMT led to sustained improvement in cardiac function, as assessed by left ventricle ejection fraction and fraction of shortening. Immunofluorescence revealed that the expressions of HSP32, HSP70 and VEGF were promoted in both transplanted bone marrow cells and recipient cardiomyocytes. RT-PCR showed that the mRNA expression levels of HSP32, HSP70 and VEGF in the BMT group were markedly higher in comparison with injection of peripheral blood cells or saline (P < 0.01) by day 7. Seven days later, the vessel count showed that angiogenesis had been induced to a significantly greater degree in the BMT groups. Fourteen days later, specific markers for myocardial or vascular endothelial cells were detected in the transplanted bone marrow cells. Conclusions: BMT upregulated the expressions of HSP32, HSP70 and VEGF in both transplanted bone marrow cells and recipient endogenous cardiomyocytes in the early phase post-transplantation. This enhanced cytoprotection and angiogenesis, and contributed to the functional recovery following cardiac infarction. In the late phase, the transplanted bone marrow cells might differentiate into both myocardial and vascular endothelial cells that enhanced the ischemic cardiac function further. (C) 2003 Elsevier B.V. All rights reserved.

P4.12 EGRESS OF FUNCTIONALLY COMPETENT PROGENITOR CELLS OVER-EXPRESSING CXCR4 FROM THE BONE MARROW FOLLOWING CARDIAC SURGERY WITH THE USE OF CARDIOPULMONARY BYPASS

Bone Marrow Resident and Circulating Progenitor Cells in Patients Undergoing Cardiac Surgery

A Novel Approach To Mobilize Bone Marrow Stem Cells With Cxcr4 Expression For Enhanced Tissue Repair In Rat Cardiac Allograft

Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing Cxcr4 Expression

Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis

CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair

Abstract 16620: Enhancing Transplanted Cardiac Progenitor Cells Homing and Survival in Ischemic Heart by CRISPR-dcas9/sgRNA-based Endogenous CXCR4 Promoter Activation

Evidence for Ischemia Induced Host-Derived Bone Marrow Cell Mobilization into Cardiac Allografts

Endothelial progenitor cells are mobilized after cardiac surgery.

Irradiation Induces Homing of Donor Endothelial Progenitor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

SDF-1/CXCR4 Axis Modulates Bone Marrow Mesenchymal Stem Cell Apoptosis, Migration and Cytokine Secretion

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

Stem Cell Homing and Angiomyogenesis in Transplanted Hearts Are Enhanced by Combined Intramyocardial Sdf-1 Alpha Delivery and Endogenous Cytokine Signaling

Mobilization of Bone Marrow-Derived Nkx2-5(+) Cardiac Progenitor Cells under Condition of Acute Myocardial Ischemia.

Hypoxic Preconditioning Improves Survival of Cardiac Progenitor Cells: Role of Stromal Cell Derived Factor-1α–CXCR4 Axis

Endothelial Progenitor Cell Homing Decreases Postoperative Complications in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Clinical experiments on marrow stem cell mobilization after off-pump coronary bypass graft

Age-dependent Mobilization of Circulating Endothelial Progenitor Cells in Infants and Young Children Undergoing Cardiac Surgery with Cardiopulmonary Bypass

CXCR4 Protects Bone Marrow-Derived Endothelial Progenitor Cells Against Hypoxia Through the PI3K/Akt Signaling Pathway

Targeted Migration of Mesenchymal Stem Cells Modified with CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance

Enhanced Cytoprotection and Angiogenesis by Bone Marrow Cell Transplantation May Contribute to Improved Ischemic Myocardial Function